Reuters
Feb 24, 2011
Samsung Group, South Korea's largest conglomerate, said on Friday it planned to set up a biopharmaceutical joint venture with initial capital of 300 billion won ($264.4 million).
To read more click here...
Friday, February 25, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment